Real-world data: High on the life science agenda
May 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing real world data, real-world data
John Wise of The Pistoia Alliance discusses the necessity of real-world data for a prosperous future for the life sciences …
Researchers identify key trigger in melanoma progression
May 3, 2017Research and Development melanoma
Researchers from life sciences research institute VIB and KU Leuven in Belgium in collaboration with INSERM, the French National Institute …
Study discovers origin of cancer metastases and why they reoccur
May 3, 2017Research and Development Cancer, metastases
A team of scientists from The Scripps Research Institute (TSRI) have discovered the secrets of where metastases originate and why …
First large-scale study gives hope for ketamine as a depression therapy
May 3, 2017Research and Development Ketamine, depression, mental health
While the development of truly innovative mental health therapies has ground to a halt somewhat, scientific research in the field …
NICE recommends Janssen’s first-of-its-kind Crohn’s drug Stelara
May 3, 2017Research and Development, Sales and Marketing Crohn’s disease, Janssen, NICE, Stelara, crohn's disease
Janssen has announced that it has secured recommendation from NICE for Stelara (ustekinumab) in the indication of moderately to severely …
UK must prioritise $17bn medtech sector in face of Brexit, new report urges
May 3, 2017Manufacturing and Production, Research and Development, Sales and Marketing Institution of Mechanical Engineers, brexit, general election, medtech
A new report from the Institution of Mechanical Engineers (IME) has highlighted the threat Brexit poses to the $17 billion …
BioIndustry Association calls for governmental support ahead of UK general election
May 2, 2017Manufacturing and Production, Sales and Marketing BIA, general election
In the run-up to the UK’s general election in June, government spending within the life sciences industry has become a …
Potential blockbuster AZ immunotherapy secures FDA approval
May 2, 2017Manufacturing and Production, Sales and Marketing AstraZeneca, bladder cancer, darzalex
The FDA has granted accelerated approval to AstraZeneca’s (AZ) immunotherapy therapy Imfinzi (durvalumab) for the treatment of locally advanced or …
Researchers control blood sugar levels in mice via smartphone app
May 2, 2017Manufacturing and Production, Research and Development diabetes
Scientists at Shanghai’s East China Normal University have been able to regulate blood sugar levels in mice via the use …
Janssen scores EU approval for blood cancer drug Darzalex
May 2, 2017Manufacturing and Production, Sales and Marketing Europe, European Commission, Janssen, darzalex
Janssen has announced that its CD38-directed monoclonal antibody Darzalex (daratumumab) has expanded its indication with a thumbs-up from the European …
Shire creates 150 jobs with Dublin HQ relocation
May 2, 2017Manufacturing and Production Dublin, Shire
Rare disease specialist Shire has opened the doors of its new headquarters in Dublin, Ireland. The pharma company has leased …
Scott Gottlieb enters final stage of approval for FDA Commissioner role
April 28, 2017Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Trump, scotrt gottlieb
Trump’s pick for the top job in the FDA moved one step closer to taking up the job when the …
Cancer Drug Fund roundly criticised as ‘wastage of resources’
April 28, 2017Medical Communications Cancer Drug Fund, Conservative, NHS, NICE, UK
The Cancer Drug Fund (CDF), which has now been absorbed into NICE, previous methods of funding have been fiercely criticised …
Top Ten most popular articles on Pharmafile.com this week
April 28, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
In response to the announcement of a UK snap election, this week saw the release of the ABPI’s 2017 General …
FDA approves first new drug for liver cancer in decade
April 28, 2017Medical Communications, Sales and Marketing Bayer, Stivarga, hepatocellular carcinoma, liver cancer
The FDA has announced that it has approved the first new treatment for hepatocellular carcinoma (HCC), a type of liver …
The five competencies of continuous regulatory compliance
April 28, 2017Medical Communications pharmafile, regulatory compliance
Look at any country or region with a strong generic pharmaceutical and active ingredient manufacturing sector, and you are sure …
SAB Biotherapeutics moves to bolster board
April 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
SAB Biotherapeutics, a clinical-stage biopharmaceutical development company, announced that it had appointed Thorkil Kastberg Christensen to its Board of Directors. …
Blood test able to detect cancer a year in advance
April 27, 2017Research and Development Cancer Research UK, Francis Crick Institute, cancer research
A team at the Francis Crick Institute, based in London, has discovered a new way of analysing blood in patients …
Mental health spending to sink by £4.5 million
April 27, 2017Medical Communications NHS, mental health
Here at Pharmafocus, we highlighted the state of mental health research and the alternative paths that are being trod to …
Mental health: Time for a new kind of therapy?
April 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing mental health
It’s no secret that mental health is not taken as seriously as its physical counterpart. It has been an uphill …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
